$VCYT
VERACYTE, INC. Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000138410122000072 Filed on May 04, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$67.78M	$36.70M
YoY Change	84.68%	17.93%
Cost Of Revenue	$23.71M	$12.40M
YoY Change	91.23%	1.31%
Gross Profit	$44.07M	$24.30M
YoY Change	81.36%	28.71%
Gross Profit Margin	65.02%	66.21%
Selling, General & Admin	$44.67M	$62.58M
YoY Change	-28.62%	146.4%
% of Gross Profit	101.35%	257.52%
Research & Development	$9.166M	$5.336M
YoY Change	71.78%	21.08%
% of Gross Profit	20.8%	21.96%
Depreciation & Amortization	$6.556M	$2.550M
YoY Change	157.1%	29.31%
% of Gross Profit	14.88%	10.49%
Operating Expenses	$53.83M	$67.91M
YoY Change	-20.74%	127.87%
Operating Profit	-$15.25M	-$45.42M
YoY Change	-66.43%	272.25%
Interest Expense	-$122.0K	$53.00K
YoY Change	-330.19%	-3.64%
% of Operating Profit
Other Income/Expense, Net	$784.0K	-$248.0K
YoY Change	-416.13%	-146.01%
Pretax Income	-$14.46M	-$45.66M
YoY Change	-68.32%	289.75%
Income Tax	-$3.000K	-$3.800M
% Of Pretax Income
Net Earnings	-$14.46M	-$41.87M
YoY Change	-65.46%	257.36%
Net Earnings / Revenue	-21.33%	-114.07%
Basic Earnings Per Share	-$0.20	-$0.66
Diluted Earnings Per Share	-$0.20	-$0.66
COMMON SHARES
Basic Shares Outstanding	71.23M shares	63.33M shares
Diluted Shares Outstanding	71.23M shares	63.33M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$163.6M	$324.1M
YoY Change	-49.52%	111.69%
Cash & Equivalents	$163.6M	$324.1M
Short-Term Investments
Other Short-Term Assets	$20.02M	$3.800M
YoY Change	426.71%	26.67%
Inventory	$12.37M	$6.308M
Prepaid Expenses
Receivables	$42.48M	$27.88M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$238.5M	$362.1M
YoY Change	-34.14%	99.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.96M	$10.56M
YoY Change	202.61%	20.19%
Goodwill	$704.4M	$474.8M
YoY Change	48.35%	17325.25%
Intangibles	$196.2M	$159.4M
YoY Change	23.09%
Long-Term Investments
YoY Change
Other Assets	$1.799M	$2.286M
YoY Change	-21.3%	75.58%
Total Long-Term Assets	$935.1M	$663.0M
YoY Change	41.03%	673.34%
TOTAL ASSETS
Total Short-Term Assets	$238.5M	$362.1M
Total Long-Term Assets	$935.1M	$663.0M
Total Assets	$1.174B	$1.025B
YoY Change	14.48%	283.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.27M	$7.137M
YoY Change	57.95%	-6.89%
Accrued Expenses	$38.54M	$16.25M
YoY Change	137.13%	61.27%
Deferred Revenue	$4.878M	$454.0K
YoY Change	974.45%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.079M
YoY Change
Total Short-Term Liabilities	$62.54M	$32.71M
YoY Change	91.21%	70.41%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0K	$863.0K
YoY Change	-30.48%	15.37%
Other Long-Term Liabilities	$1.378M	$16.60M
YoY Change	-91.7%	-0.6%
Total Long-Term Liabilities	$1.378M	$863.0K
YoY Change	59.68%	15.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.54M	$32.71M
Total Long-Term Liabilities	$1.378M	$863.0K
Total Liabilities	$88.40M	$50.91M
YoY Change	73.65%	38.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$371.6M	-$323.5M
YoY Change	14.89%	25.18%
Common Stock	$1.477B	$1.298B
YoY Change	13.86%	165.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.085B	$974.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.174B	$1.025B
YoY Change	14.48%	283.8%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$14.46M	-$41.87M
YoY Change	-65.46%	257.36%
Depreciation, Depletion And Amortization	$6.556M	$2.550M
YoY Change	157.1%	29.31%
Cash From Operating Activities	-$8.872M	-$40.56M
YoY Change	-78.13%	665.16%
INVESTING ACTIVITIES
Capital Expenditures	$2.453M	$1.196M
YoY Change	105.1%	79.85%
Acquisitions	$0.00	$574.4M
YoY Change	-100.0%
Other Investing Activities	$0.00	-$574.4M
YoY Change	-100.0%
Cash From Investing Activities	-$2.453M	-$575.6M
YoY Change	-99.57%	86457.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$100.0K	$0.00
YoY Change
Cash From Financing Activities	$1.990M	$591.0M
YoY Change	-99.66%	-269968.49%
NET CHANGE
Cash From Operating Activities	-$8.872M	-$40.56M
Cash From Investing Activities	-$2.453M	-$575.6M
Cash From Financing Activities	$1.990M	$591.0M
Net Change In Cash	-$9.582M	-$25.16M
YoY Change	-61.91%	306.73%
FREE CASH FLOW
Cash From Operating Activities	-$8.872M	-$40.56M
Capital Expenditures	$2.453M	$1.196M
Free Cash Flow	-$11.33M	-$41.76M
YoY Change	-72.88%	599.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	us-gaap	Defined Benefit Plan Type Extensible List DefinedBenefitPlanTypeExtensibleList	http://fasb.org/us-gaap/2021-01-31#PensionPlansDefinedBenefitMember
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36156
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5455398
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6000 Shoreline Court
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
CY2022Q1	dei	City Area Code CityAreaCode	(650)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	243-6300
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value, $0.001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	VCYT
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71445343	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163615000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173197000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42481000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41461000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12372000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	11225000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20015000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17219000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	238483000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	243102000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	16299000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	15098000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15663000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16043000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	196228000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	202731000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	704368000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	707904000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1799000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2198000	USD
CY2022Q1	us-gaap	Assets Assets	1173589000	USD
CY2021Q4	us-gaap	Assets Assets	1187825000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11273000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12360000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38543000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39475000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1079000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1127000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4878000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4646000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2703000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2682000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3849000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3630000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	218000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	231000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	62543000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	64151000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	278000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	343000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4983000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5592000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5732000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5722000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13485000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14096000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1378000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1407000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	88399000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	91311000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71432875	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71432875	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71123108	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71123108	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	71000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	71000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1477418000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1468683000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-371618000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-357157000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20681000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15083000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1085190000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1096514000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1173589000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1187825000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67783000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36703000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9166000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5336000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	23754000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16296000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20912000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1801000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46282000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5486000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	83031000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	82118000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15248000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-45415000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	784000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-248000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14464000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45663000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3795000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-14461000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71229672	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71229672	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63331702	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63331702	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-14461000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5598000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20059000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41868000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1096514000	USD
CY2022Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod	1422000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2115000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1447000	USD
CY2022Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	6230000	USD
CY2022Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Non Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee	11000	USD
CY2022Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	404000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-14461000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5598000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1085190000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	421232000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	38677000	USD
CY2021Q1	vcyt	Stock Issued And Sold During Period Value In Private Placement StockIssuedAndSoldDuringPeriodValueInPrivatePlacement	593821000	USD
CY2021Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod	2806000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1159000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6774000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	3657000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Non Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee	16000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	182000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	974231000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-14461000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6556000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2550000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6645000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3855000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3795000	USD
CY2022Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty	53000	USD
CY2021Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty	53000	USD
CY2022Q1	vcyt	Noncash Lease Expense NoncashLeaseExpense	587000	USD
CY2021Q1	vcyt	Noncash Lease Expense NoncashLeaseExpense	258000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	31000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	192000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-131000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-82000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3575000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3748000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1201000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2139000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-132000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-451000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-597000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-373000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-960000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1931000	USD
CY2022Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue	-390000	USD
CY2021Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue	238000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8872000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40561000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	574411000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2453000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1196000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2453000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-575607000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	593821000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	100000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1447000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6774000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3537000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3965000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1990000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	591012000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9335000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-25156000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-247000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9582000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25156000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	173946000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	349967000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	164364000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324811000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	342000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	357000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163615000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173197000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	164364000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	173946000	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; the useful lives of property and equipment; the recoverability of long-lived assets; the incremental borrowing rate for leases; accounting for acquisitions; the estimation of the fair value of intangible assets and contingent consideration; stock based compensation; income tax uncertainties, including a valuation allowance for deferred tax assets; an allowance for credit losses and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</span></div>
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2022Q1	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1000000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1100000	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5293818	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4847191	shares
CY2022Q1	us-gaap	Goodwill Goodwill	704400000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	707900000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	220757000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31829000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	188928000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	221838000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26407000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	195431000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y10M24D
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	228057000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31829000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	196228000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	229138000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26407000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5500000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	202731000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	16431000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	21908000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	21868000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20725000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	18844000	USD
CY2022Q1	vcyt	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	89152000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	188928000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9100000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8200000	USD
CY2022Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	3300000	USD
CY2021Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	3000000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29525000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30792000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9018000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8683000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38543000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39475000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3450000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4672000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4431000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4482000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1402000	USD
CY2022Q1	vcyt	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	1570000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	20007000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2673000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	17334000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3849000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13485000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1054000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	575000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1068000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	588000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	600000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	600000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	700000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	600000	USD
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	13335815	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	10800658	shares
CY2022Q1	vcyt	Other Nonoperating Income Expense Foreign Tax Credit OtherNonoperatingIncomeExpenseForeignTaxCredit	892000	USD
CY2021Q1	vcyt	Other Nonoperating Income Expense Foreign Tax Credit OtherNonoperatingIncomeExpenseForeignTaxCredit	0	USD
CY2022Q1	vcyt	Other Nonoperating Income Expense Interest Income OtherNonoperatingIncomeExpenseInterestIncome	39000	USD
CY2021Q1	vcyt	Other Nonoperating Income Expense Interest Income OtherNonoperatingIncomeExpenseInterestIncome	43000	USD
CY2022Q1	vcyt	Other Nonoperating Income Expense Interest Expense OtherNonoperatingIncomeExpenseInterestExpense	61000	USD
CY2021Q1	vcyt	Other Nonoperating Income Expense Interest Expense OtherNonoperatingIncomeExpenseInterestExpense	53000	USD
CY2022Q1	vcyt	Other Nonoperating Income Expense Foreign Currency Translation Gain Loss OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss	-100000	USD
CY2021Q1	vcyt	Other Nonoperating Income Expense Foreign Currency Translation Gain Loss OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss	-238000	USD
CY2022Q1	vcyt	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	14000	USD
CY2021Q1	vcyt	Other Nonoperating Income Expense Other OtherNonoperatingIncomeExpenseOther	0	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	784000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-248000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000	USD

Files In Submission

Name	View Source	Status
0001384101-22-000072-index-headers.html	Edgar Link	pending
0001384101-22-000072-index.html	Edgar Link	pending
0001384101-22-000072.txt	Edgar Link	pending
0001384101-22-000072-xbrl.zip	Edgar Link	pending
ex101executiveemploymentag.htm	Edgar Link	pending
ex102cicseveranceagreement.htm	Edgar Link	pending
ex103anniemcguireofferlett.htm	Edgar Link	pending
ex104cicandseveranceagreem.htm	Edgar Link	pending
ex105jalleytransitionandse.htm	Edgar Link	pending
ex106employmentagreementbo.htm	Edgar Link	pending
exhibit31103-31x2022.htm	Edgar Link	pending
exhibit31203-31x2022.htm	Edgar Link	pending
exhibit32103-31x2022.htm	Edgar Link	pending
exhibit32203-31x2022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01a.jpg	Edgar Link	pending
image_03a.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_2a.jpg	Edgar Link	pending
image_31a.jpg	Edgar Link	pending
image_5.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-20220331.htm	Edgar Link	pending
vcyt-20220331.xsd	Edgar Link	pending
vcyt-20220331_cal.xml	Edgar Link	unprocessable
vcyt-20220331_def.xml	Edgar Link	unprocessable
vcyt-20220331_htm.xml	Edgar Link	completed
vcyt-20220331_lab.xml	Edgar Link	unprocessable
vcyt-20220331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
VERACYTE, INC. Stock $vcyt

2022 Q1 Form 10-Q Financial Statement

#000138410122000072 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT VERACYTE, INC. Stock $vcyt

2022 Q1 Form 10-Q Financial Statement

#000138410122000072 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
VERACYTE, INC. Stock $vcyt